| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.3 | 7e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.26 | 5e-07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.082 | 0.1 |